Opiate withdrawal increases ProTRH gene expression in the ventrolateral column of the midbrain periaqueductal gray

Brain Research

Volumn 729, Issue 1, 1996, Pages 10-19

  Légrádi, Gábor ^a   Rand, William M ^b   Hitz, Sherri ^a   Nillni, Eduardo A ^c   Jackson, Ivor M D ^c   Lechan, Ronald M ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Hybridization histochemistry in situ; Immunohistochemistry; Opiate withdrawal; Periaqueductal gray; ProTRH; Rat

Indexed keywords

MORPHINE; NALTREXONE; PROTIRELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030570739     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00210-7     Document Type: Article

References (52)

1. [1] Bandler, R., Carrrive, P. and Depaulis, A., Emerging principles of organization of the midbrain periaqueductal gray matter. In A. Depaulis, R. Bandler (Eds.), The Midbrain Periaqueductal Gray Matter, Plenum Press, New York, 1991, pp. 1-8.
2. [2] Bandler, R., Carrive, P. and Zhang, S.P., Integration of somatic and autonomic reactions within the midbrain periaqueductal grey: viscerotopic, somatotopic and functional organization. Prog. Brain Res., 87 (1991) 269-305.
3. [3] Bandler, R. and Shipley, M.T., Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci., 17 (1994) 379-389.
4. [4] Bennett, G.W., Marsden, C.A., Fone, K.C.F., Johnson, J.V. and Heal, D.J., TRH-natecholamine interactions in brain and spinal cord, Ann. NY Acad. Sci., 553 (1989) 106-120.
5. [5] Bläsig, J., Herz, A., Reinhold, K. and Zieglgansberger, S., Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia, 33 (1973) 19-38.
6. [6] Bulant, M., Beauvillain, J.C., Delfour, A., Vaudry, H. and Nicolas, P., Processing of thyrotropin-releasing hormone (TRH) prohormone in the rat olfactory bulb generates novel TRH-related peptides, Endocrinology, 127 (1990) 1978-1985.
7. [7] Bulant, M., Delfour, A., Vaudry, H. and Nicolas, P., Processing of thyrotropin-releasing hormone prohormone (pro-TRH) generates pro-TRH-connecting peptides, J. Biol. Chem., 263 (1988) 17189-17196.
8. [8] Bulant, M., Roussel, J-P., Astier, H., Nicolas, P. and Vaudry, H., Processing of thyrotropin-releasing hormone prohormone (pro-TRH) generates a biologically active peptide, prepro-TRH-(160-169), which regulates TRH-induced thyrotropin secretion, Proc. Natl. Acad. Sci. USA, 87 (1990) 4439-4443.
9. [9] Cameron, A.A., Khan, I.A., Westlund, K.N., Cliffer, K.D. and Willis, W.D., The efferent projections of the periaqueductal gray in the rat: a Phaseolus vulgaris-leucoagglutinin study. I. Ascending projections, J. Comp. Neurol., 351 (1995) 568-584.
10. [10] Cameron, A.A., Khan, I.A., Westlund, K.N. and Willis, W.D., The efferent projections of the periaqueductal gray in the rat: a Phaseolus vulgaris-leucoagglutinin study. II. Descending projections, J. Comp. Neurol., 351 (1995) 585-601.
11. [11] Carr, F.E., Fein, H.G., Fisher, C.U., Wessendorf, M.W. and Smallridge, R.C., Cryptic peptide (160-169) of thyrotropin-releasing hormone prohormone demonstrates biological activity in vivo and in vitro, Endocrinology, 131 (1992) 2653-2658.
12. [12] Carr, F.E., Reid, A.M. and Wessendorf, M.W., A cryptic peptide from the preprothyrotropin-releasing hormone precursor stimulates thyrotropin gene expression, Endocrinology, 133 (1993) 809-814.
13. [13] Chieng, B., Keay, K.A. and Christie, M.J., Increased fos-like immunoreactivity in the periaqueductal gray of anesthetized rats during opiate withdrawal, Neurosci. Lett., 183 (1995) 79-82.
14. [14] Cockle, S.M., TRH-extended peptides in olfactory lobe are formed by incomplete cleavage at pairs of arginine residues in the TRH prohormone, FEBS Lett., 264 (1990) 253-256.
15. [15] Depaulis, A., Keay, K.A. and Bandler, R., Longitudinal neuronal organization of defensive reactions in the midbrain periaqueductal grey region of the rat, Exp. Brain Res., 90 (1992) 307-318.
16. [16] Depaulis, A., Keay, K.A. and Bandler, R., Quiescence and hyporeactivity evoked by activation of cell bodies in the ventrolateral midbrain periaqueductal gray of the rat, Exp. Brain Res., 99 (1994) 75-83.
17. [17] Eipper, B.A. and Mains, R.E., Structure and biosynthesis of proadrenocorticotropin, endorphin and related peptides, Endocrinol. Rev., 1 (1980) 1-27.
18. [18] Friedman, T.C., Loh, P.Y., Cawley, N.X., Birch, P., Huang, S.S., Jackson, I.M.D. and Nillni, E.A., Processing of pro-TRH by bovine intermediate lobe secretory vesicle membrane PC1 and PC2 enzymes, Endocrinology, 136 (1995) 4462-4472.
19. [19] Jackson, I.M.D., Lechan, R.M. and Lee, S.L., TRH prohormone: Biosynthesis, anatomic distribution, and processing, Front. Neuroendocrinol., 11 (1990) 267-312.
20. [20] Jackson, I.M.D. and Reichlin, S., Thyrotropin-releasing hormone (TRH): distribution in hypothalamic and extrahypothalamic brain tissues of mammalian and submammalian chordates, Endocrinology, 95 (1974) 854-862.
21. [21] Keay, K.A., Clement, C.I., Owler, B., Depaulis, A. and Bandler, R., Convergence of deep somatic and visceral nociceptive information onto a discrete ventrolateral midbrain periaqueductal gray region, Neuroscience, 61 (1994) 727-732.
22. [22] Kelsey, J.E. and Arnold, S.R., Lesions of the dorsomedial amygdala, but not the nucleus accumbens, reduce the aversiveness of morphine withdrawal in rats, Behav. Neurosci., 6 (1994) 1119-1127.
23. [23] Koob, G.F., Maldonado, R.and Stinus, L., Neural substrates of opiate withdrawal, Trends Neurosci, 15 (1992) 186-191.
24. [24] Koob, G.F., Wall, T.L. and Bloom, F.E., Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal, Psychopharmacology, 98 (1989) 530-534.
25. [25] Ladram, A., Bulant, M., Montagne, J-J. and Nicolas, P., Distribution of TRH-potentiating peptide (PS4) and its receptors in rat brain and peripheral tissues, Biochem. Biophys. Res. Commun., 200 (1994) 958-965.
26. [26] Lechan, R.M. and Jackson, I.M.D., Immunohistochemical localization of thyrotropin-releasing hormone in the rat hypothalamus and pituitary, Endocrinology, 111 (1982) 55-65.
27. [27] Lechan, R.M. and Segerson, T.P., Pro-TRH gene expression and precursor peptides in rat brain, Ann. NY Acad. Sci., 553 (1989) 29-59.
28. [28] Lechan, R.M. and Toni, R., Thyrotropin-releasing hormone neuronal systems in the central nervous system. In C.B. Nemeroff (Ed.), Neuroendocrinology, CRC Press, Boca Raton, 1992, pp. 279-330.
29. [29] Lechan, R.M., Wu, P. and Jackson, I.M.D., Immunocytochemical distribution in rat brain of putative peptides derived from thyrotropin-releasing hormone prohormone, Endocrinology, 121 (1987) 1879-1891.
30. [30] Lechan, R.M., Wu, P., Jackson, I.M.D., Wolfe, H., Cooperman, S., Mandel, G. and Goodman, R.H., Thyrotropin-releasing hormone precursor: characterization in rat brain. Science, 231 (1986) 159-161.
31. [31] Liao, N., Bulant, M., Nicolas, P., Vaudry, H. and Pelletier, G. Immunocytochemical distribution of neurons contaning a peptide derived from thyrotropin-releasing hormone precursor in the rat brain, Neurosci. Lett., 85 (1988) 24-28.
32. [32] Lovick, T., Integrated activity of cardiovascular and pain regulatory systems: role in adaptive behavioural responses, Prog. Neurobiol., 40 (1993) 631-644.
33. [33] Miczek, K.A., Thompson, M.L. and Schuster, L., Opioid-like analgesia in defeated mice, Science, 215 (1982) 1520-1522.
34. [34] Nillni, E.A., Friedman, T.C., Todd, R.B., Birch, N.P., Loh, P. and Jackson, I.M.D., ProTRH processing by recombinant PC1, J. Neurochem., 65 (1995) 2462-2472.
35. [35] Nillni, E.A., Sevarino, K.A. and Jackson, I.M.D., Identification of the thyrotropin-releasing hormone-prohormone and its posttranslational processing in a AtT20 tumoral transfected cell line, Endocrinology, 132 (1993) 1260-1270.
36. [36] Pothos, E., Rada, P., Mark, G.P. and Huebel, E.G., Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone precipitated withdrawal and clonidine treatment, Brain Res., 566 (1991) 348-350.
37. [37] Rasmussen, K., Beitner-Johnson, D.B., Krystal, J.H., Aghajanian, G.K. and Nestler, E.J., Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates, J. Neurosci., 10 (1990) 2308-2317.
38. [38] Redei, E., Hilderbrand, H. and Aird, F., Corticotropin release inhibiting factor is encoded within prepro-TRH, Endocrinology, 136 (1995) 1813-1816.
39. [39] Redei, E., Hilderbrand, H. and Aird, F., Corticotropin release-inhibiting factor is preprothyrotropin-releasing hormone-(178-199), Endocrinology, 136 (1995) 3557-3563.
40. [40] Reichlin, S., Neural functions of TRH, Acta Endocrinol., 276 (1986) 21-33.
41. [41] Robertson, J.A. and Bodnar, R.J., Site-specific modulation of morphine and swim-induced antinociception following thyrotropin-releasing hormone in the rat periaqueductal gray, Pain, 55 (1993) 71-84.
42. [42] Rossetti, Z.L., Hmaidan, Y. and Gessa, G.L., Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats, Eur. J. Pharmacol., 221 (1992) 227-234.
43. [43] Rossi, F., Maione, S. and Berino, L., Periaqueductal gray area and cardiovascular function, Pharmacol. Res., 29 (1994) 27-36.
44. 2+ channels, Neuroendocrinology, 54 (1991) 559-565.
45. [45] Segerson, T.P., Kauer, J., Wolfe, H.C., Mobtaker, H., Wu, P., Jackson, I.M.D. and Lechan, R.M., Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus, Science. 238 (1987) 78-80.
46. [46] Valentijn, K., Bunel, D.T., Liao, N., Pelletier, G. and Vaudry, H., Release of pro-thyrotropin-releasing hormone connecting peptides PS4 and PS5 from perifused rat hypothalamic slices, Neuroscience, 44 (1991) 223-233.
47. [47] Valentijn, K., Bunel, D.T. and Vaudry, H., ω-Conotoxin and nifedipine-insensitive voltage-operated calcium channels mediate potassium-induced release of pro-thyrotropin-releasing hormone-connecting peptides PS4 and PS5 from perifused rat hypothalamic slices, Mol. Brain Res., 14 (1992) 221-230.
48. 53-74) are present in a unique location of the midbrain periaqueductal gray of the rat, Brain Res., 461 (1988) 53-63.
49. [49] Wall, P.D., On the relation of injury to pain, Pain, 6 (1979) 253-264.
50. [50] Webster, V.A.D., Giffiths, E.G. and Slater, P., Antinociceptive effects of thyrotropin-releasing hormone and its analogues in the rat periaqueductal gray region, Neurosci. Lett., 42 (1983) 67-70.
51. [51] Wu, P., Lechan, R.M. and Jackson, I.M.D., Identification and characterization of thyrotropin releasing hormone precursor peptides in rat brain, Endocrinology, 121 (1987) 108-115.
52. [52] Yang, H. and Tache, Y., Prepro-TRH-(160-169) potentiates gastric acid secretion stimulation by TRH microinjected into the dorsal motor nucleus of the vagus, Neurosci. Lett., 174 (1994) 43-50.